Chammas & Marcheteau advised Yotta Capital Partners on its acquisition of a majority stake in SEDI-ATI. Yotta Capital Partners, the leading French investment fund dedicated to...
You must be a Standard 1 Year member to access this content.
Chammas & Marcheteau advised a consortium of investment funds. The sellers were advised by Lamartine Conseil. The management was advised by Lamartine Conseil. The senior lenders...
You must be a Standard 1 Year member to access this content.
Chammas & Marcheteau advised Extens on the acquisition (majority LBO). Extens, a renowned digital health fund, has announced the acquisition of a majority stake in Val...
You must be a Standard 1 Year member to access this content.
Chammas & Marcheteau advised Xelya and the sellers in the framework of the OBO. Goodwin and MB Avocats advised Parquest. The founders of Xelya, together with...
You must be a Standard 1 Year member to access this content.
Arsène Taxand and Valther advised Diot-Siaci. Chammas & Marcheteau advised the founder of Sol Mondo. The Diot-Siaci group has announced the acquisition of Sol Mondo, an...
You must be a Standard 1 Year member to access this content.
Chammas & Marcheteau and CNPLaw LLP advised Shift4Good SAS on the deal. CNP also advised Hera Capital Partners Pte Ltd. Singapore and France-based venture capital fund...
You must be a Standard 1 Year member to access this content.
McDermott Will & Emery advised Diabeloop on the deal. Chammas & Marcheteau advised LBO France. Diabeloop, a Grenoble-based artificial intelligence company specialising in the treatment of...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised Treatwell France on the deal. Chammas & Marcheteau advised Wavy. The Treatwell group – the leading beauty and wellness site and app in...
You must be a Standard 1 Year member to access this content.
Chammas & Marcheteau advised Turenne Capital on the deal while Bird & Bird represented Domain Therapeutics. Jones Day advised CTI Life Sciences Fund, Panacea Venture, and...
You must be a Standard 1 Year member to access this content.
Chammas & Marcheteau advised Turenne Capital on the deal. Lavery de Billy and Bird & Bird represented Domain Therapeutics. Jones Day advised CTI Life Sciences Fund,...
You must be a Standard 1 Year member to access this content.
IN BRIEF: August & Debouzy, Chammas & Marcheteau, advised on the matter. August & Debouzy advised Aptiv PLC with a team including Alexandra Berg-Moussa (IP&IT), Florence...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Chammas & Marcheteau, advised on the matter. Chammas & Marcheteau advised Maltem Consulting Group with a team including J??e Chapron (Corporate M&A), Denis Marcheteau...
You must be a Standard 1 Year member to access this content.
